Clinical Trials Details

Brain Cancer

Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma

Trial ID: 09057

Contact: Denise L Elmore

Phone: (281)863-4609

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
New York Oncology Hematology, P.C.	Albany, NY (Patroon)
Texas Oncology, P.A.	Arlington, TX (South)
Texas Oncology, P.A.	Bedford, TX (Edwards CC)(RAD)
Texas Oncology, P.A.	Bedford, TX (Harris HEB)
Texas Oncology, P.A.	Fort Worth, TX (12th Ave.)
Texas Oncology, P.A.	Fort Worth, TX (8th) Rad Only
Texas Oncology, P.A.	Fort Worth, TX (Klabzuba) Rad
Central Indiana Cancer Centers	Indianapolis, IN (E. County)
Kansas City Cancer Center, LLC.	Kansas City, MO (North)
Texas Oncology, P.A.	Odessa, TX
Texas Oncology, P.A.	Sherman, TX
Texas Oncology, P.A.	Sugar Land, TX
Arizona Oncology Associates, PC - SRO	Tucson, AZ (Orange Grove Rd)
Arizona Oncology Associates, PC - HOPE	Tucson, AZ (Rudasill - HOPE)